APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: At 60 min post-injection, 40% (p < 0.01 vs. CML alone group), 47% (p < 0.001 vs. CML alone group), and 67% (p < 0.001 vs. CML alone group) of zebrafish restored their swimming ability in 1:0.1, 1:0.5, and 1:1 molar ratio of apoA-I:CIGB-258.